Titan Spine Raises Capital to Support nanoLOCK Interbody Fusion Devices

Titan Spine closed a substantial round of financing for an undisclosed amount with its investor, Southlake Equity. Proceeds will support U.S. sales expansion and surgeon adoption of Endoskeleton® titanium interbody fusion implants and launch of next-generation nanoLOCK™ surface technology. Update, 7/15/16: In Xconomy, Editor...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us